Revelation Pharma Completes Thirteenth Acquisition – Purchases Clinical Community Pharmacy
TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the thirteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Community Clinical Pharmacy located in Mesa, Arizona. Community Clinical Pharmacy is a 503A compounding pharmacy with more than 42 years of expertise, offering patients and healthcare professionals the highest quality compounded preparations to help optimize health.
The purchase of Community Clinical Pharmacy highlights Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life.
“We’re excited to join the Revelation family of pharmacies. Through Revelation’s vision and market-leading expertise, we look forward to Community Clinical Pharmacy’s ability to help our community with all of their compounding needs to our 50th anniversary and beyond”, said Kris Kaniski, PharmD.
The corporate team for Revelation is led by Pharmacist Shawn Hodges, the former CEO and President of Innovation Compounding, now current CEO of Revelation. Serving as Chairman of the Board, Pharmacist Jake Beckel, has deep experience in the compounding space. He most recently served as founder and CEO of AnazaoHealth Corporation, a leading compounding pharmacy that successfully completed 13 acquisitions and ultimately was acquired by Fagron, the world’s largest publicly traded compounding company. Richard Case serves as President M&A; he is a healthcare M&A industry veteran and has significant experience in the acquisitions of healthcare businesses that operate in highly regulatedindustries. Jake Beckel and Richard Case, the founders of Revelation, who sit on the board of directors, will solely focus on helping new companies that wish to join Revelation. Mitchell Bell PharmD., is the Senior Vice President of 503A Pharmacies and was previously the Vice President of Operations at Innovation Compounding. Will Skinner is the Chief Financial Officer who has specialized in start-ups, alternative investment companies, and healthcare organizations. Jon Pritchett PharmD., former Pharmacy Program Director at Accreditation Commission for Health Care (ACHC), now serves as the Vice President of Quality Assurance and Regulatory Affairs.
The number of pharmaceutical collaborations in the works is gradually increasing. Even while pharmacy owners acknowledge the need for support in reacting to regulatory changes, they still wish to undertake pharmacy compounding and serve their patients’ particular healthcare requirements. Revelation’s long-term goal is to become the market leader in compounding by supporting and acquiring pharmacies while building a complete quality assurance system throughout the whole network.
About Osceola Capital Management
Osceola Capital is a Tampa-based private equity firm that invests in lower middle-market services companies, typically with EBITDA of $2 million to $10 million. Osceola has extensive experience partnering with management teams to execute buy-and-build strategies and drive long-term value creation. The Revelation Strategy Team includes Ben Moe, and Patrick Watkins. To learn more, visit www.osceola.com.
About Revelation Pharma Corporation
Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmaceutical products and services through “industry best” patient care and solutions for customers. Compounding pharmacy will drastically change in the next five years. Revelation believes that compounding pharmacies will need help and support to adjust to these changes in order to continue to serve the needs of the patient and their healthcare provider.
About Community Clinical Pharmacy
Community Clinical Pharmacy has been serving the state of Arizona since 1980. Community Clinical Pharmacy prides itself on working directly with medical providers to formulate medications that will optimize patients’ health and quality of life.
Director of Marketing Communications